Nov 10 Webinar: Breakthroughs in Tissue Regeneration

Nov 10 Webinar: Breakthroughs in Tissue Regeneration

Learn more about NEW indications and use for fish-skin graft products

This webinar will address

• Prevention • Surgical Site Complications and prevention • Basic science of fish skin for tissue reinforcement • Application techniques of fish-skin graft • Case reviews • Future research

Kerecis®️, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, has received authorization from the FDA to market Kerecis Omega3 SurgiBind™️. The product, which is available now in the United States, is an implantable fish-skin graft for use in plastic and reconstructive surgery. The product is indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair, or reinforcement in plastic or reconstructive surgery. 

Dr. Lantis will discuss:

  • Prevention of wound complications
  • Science behind SurgiBind
  • Case reviews: Utilization of Kerecis for reinforcement of soft tissue under primary closure

Dr. Crespo Soto will address:

  • Algorithms for optimal patient outcomes
  • Case reviews: utilizing SurgiBind in at risk procedures such as lower leg resection, amputations and vascular grafting

Dr. Lantis is the Professor of Surgery at Ichan School of Medicine, and Vice Chair of Surgery and Chief of Vascular/Endovascular Surgery at Mount Sinai Morningside and West Hospitals in New York. Dr Lantis’ clinical practice spans the fields of Vascular/Endovascular Surgery, and lower extremity wound healing. He directs a clinical/basic science research program in the field of lower extremity wound healing and tissue repair and is published extensively. He is a founding member of the American Board of Wound Medicine and Surgery. He currently sits on the editorial board of WOUNDS, and is a reviewer for half a dozen other journals. To date he is/or has been the principal investigator on more than 55 multi center and single center chronic wound and vascular surgery trials. 

Vascular surgeon Dr. Crespo Soto of the Sanger Heart and Vascular Institute of Atrium Health was the first physician to use SurgiBind commercially outside of a study. “I used the product in a ray amputation surgery, and I was pleased with the outcome. There were no post-op complications; the incision stayed closed and healed quickly. The Kerecis product compliments surgical procedures, provides a bacterial barrier and reinforces the body’s healing mechanism.”